Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Oncogenicity and Therapeutic Implications of Molecular Biomarkers in Colorectal Carcinoma.
Journal: Surgical pathology clinics
Published: May 06, 2026
Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma.
Journal: Gynecologic oncology
Published: July 21, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.
Journal: Cancer research communications
Published: March 24, 2025
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors.
Journal: JCO precision oncology
Published: November 20, 2024
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors.
Journal: The oncologist
Published: June 17, 2024
Charting the Genomic Frontier: 25 Years of Evolution and Future Prospects in Molecular Diagnostics for Solid Tumors.
Journal: The Journal of molecular diagnostics : JMD
Published: June 09, 2024
Molecular Approach to Colorectal Carcinoma: Current Evidence and Clinical Application.
Journal: Clinics in laboratory medicine
Published: May 31, 2024
Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal Carcinoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 03, 2024
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 08, 2024
Her2 low (but not negative): the newest biomarker on the block for gastro-oesophageal adenocarcinoma.
Journal: Journal of clinical pathology
Published: August 06, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 05, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 09, 2022
Last Updated: 09/26/2026